Purpose/ Objective

The pathophysiology of repaired TOF is complex. Patients often tolerate the chronic volume load imposed by pulmonary regurgitation and, in some patients, by tricuspid regurgitation and residual intracardiac shunt(s), for many years. In other patients, the pathophysiology is further complicated by abnormalities in the pulmonary arterial tree. Over time, however, the risks of ventricular dysfunction, exercise intolerance, heart failure symptoms, arrhythmias, and death increase substantially. CMR has evolved to become a crucial diagnostic tool in this growing patient population. Following this activity, learners will understand the role of CMR in the management of tetralogy of Fallot, novel CMR techniques for assessing tetralogy of Fallot and be able to discuss protocol for a CMR exam in tetralogy of Fallot.

Accreditation Statement

The Society for Cardiovascular Magnetic Resonance (SCMR) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation Statement

The Society for Cardiovascular Magnetic Resonance (SCMR) designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit (s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Instructions for Claiming CME

• Attend the sessions in full for which credit is sought
• Complete the post-activity evaluation
• A certificate of completion will be available once the evaluation is submitted

Financial Disclosures

The planners and faculty for this activity did not have any relevant relationships to disclose, unless listed below:
 

Dr. Kroft received research support from Bayer Schering Pharma, Siemens and Philips.

Any resulting conflicts of interest were resolved prior to the start of the activity according to ACCME Criteria & Standards.

Disclosure of Commercial Support

SCMR received no funding to support this activity.

Bibliography

• Morales, ATS 2009
• Geva, JCMR 2011
• Therrien, Am J Card 2005
• Oosterhoff, Circ 2007
• Gatzoulis et al, Circ 1995
• Helbing et al, JACC 1996
• Lee et al, Int J Card 2013
• Maskatia, Cong Heart Disease 2015
• Maskatia et al, Am J Card 2013
• Chen et al, Am H Journal 2014
• Cheung et al, Am J Card 2010
• Wald et al, Circulation 2009
• O’Meager et al, Heart Lung Circ 2014
• Olive, Maskatia, et al, AHA scientific sessions 2014
• Narayan et al, Circulation 2006
• Chen et al, JACC Imaging 2016
• JAMA 1945;128:189-202
• Lillehei Surgery 1955;38:11-29
• Bach, J Thor Cardiovasc Surgery 2001
• Warnes et al, Circulation 2008;118:2395
• Therrien et al. Am J Cardiol. 2005;95:779
• Geva T JCMR 2011;13:9
• Babu-Narayan et al, Circulation 2006;113:405
• Broberg Circ Cardiovasc Imaging 2010;3:727
• Oosterhoff T, et al Am Heart J 2005;151:265-272
• Viegen HW et al Circulation 2002;106:1703-7
• Henies IR et al Ann Thor Surg 2007;83:907-911
• Oosterhoff et al Circulation 2007; 116:545-551
• Geva T et al J Am Col Cardiol 2004;43:105874
• Apitz C et al Lancet 2009;374:1462-71
• Therrien J et al AM J Cardol 2005;95:779-82
• Buechel ERV et al Eur Heart J 2005;25:2721-27
• Apitz C, Webb GD, Redington AN, Lancet 2009;374:1462-71
• Gatzoulis MA et al Circualtion 1995;81:1175-81
• Redington AN et al Cardiol Young 1992;2:383-86
• Grotenhuis HB, Kroft LJM et al 2006 Ch27 MRI and CT Higginside Roos (eds)
• Van Straten et al Radiology 2004;233:824-29
• Van Straten A et al JACC 2005;46:1559-1564
• Van der Hulst AE et al Radiology 2010;256:724-734
• Gartner RD et al J Thor Imag 2010;25:183-190
• Oosterhoff et al Radiology 2005;237:868-371